Detection of biomarkers for esophageal cancer pathologic complete response (pathCR) in OE33 and NCI-H460 control cell lines using a clinical standard operating procedure (SOP) protocol.
Robert W. Cook
Employment or Leadership Position - Castle Biosciences
Stock Ownership - Castle Biosciences
Research Funding - Castle Biosciences
Jaffer A. Ajani
No relevant relationships to disclose
Landon Inge
Research Funding - Castle Biosciences